Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
8.12
0.27 (3.44%)
At close: Sep 26, 2025, 1:13 PM
Xeris Biopharma Revenue
Xeris Biopharma reported an annual revenue of $203.07M, reflecting a 23.89% growth. For the quarter ending June 30, 2025, Xeris Biopharma generated $71.54M in revenue.
Revenue (ttm)
203.07M
Revenue Growth
23.89%
Price / Sales Ratio
2.45
Revenue / Employee
515.41K
Employees
394
Market Cap
1.31B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 203.07M | +23.89% |
| Dec 31, 2023 | 163.91M | +48.68% |
| Dec 31, 2022 | 110.25M | +122.32% |
| Dec 31, 2021 | 49.59M | n/a |
| Dec 31, 2020 | 49.59M | +146.04% |
| Dec 31, 2019 | 20.16M | +717.65% |
| Dec 31, 2018 | 2.46M | +58.42% |
| Dec 31, 2017 | 1.56M | +44.74% |
| Dec 31, 2016 | 1.07M | n/a |